首页> 外文期刊>Annals of Surgery >Antibiotic prophylaxis at urinary catheter removal prevents urinary tract infections: a prospective randomized trial.
【24h】

Antibiotic prophylaxis at urinary catheter removal prevents urinary tract infections: a prospective randomized trial.

机译:导尿管切除术预防抗生素预防尿路感染:一项前瞻性随机试验。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To assess whether antibiotic prophylaxis at urinary catheter removal reduces the rate of urinary tract infections. SUMMARY OF BACKGROUND DATA: Urinary tract infections are among the most common nosocomial infections. Antibiotic prophylaxis at urinary catheter removal is used as a measure to prevent them, albeit without supporting evidence. METHODS: A prospective randomized study enrolled 239 patients undergoing elective abdominal surgery, who were randomized either for receiving 3 doses of trimethoprim-sulfamethoxazole at urinary catheter removal, or not. Urinary tract infections were diagnosed according to Center of Disease Control definitions. Urinary cultures were obtained before and 3 days after catheter removal. Subjective symptoms were assessed by an independent study-blind urologist. RESULTS: Patients who received antibiotic prophylaxis showed significantly fewer urinary tract infections (5/103, 4.9%) than those without prophylaxis (22/102, 21.6%), P < 0.001. The absolute risk reduction for the occurrence of a urinary tract infection was 16.7%; the relative risk reduction was 77.5%, and the number needed to treat was 6. Patients with antibiotic prophylaxis also had less significant bacteriuria 3 days after catheter removal (17/103, 16.5%) than those without (42/102, 41.2%), P < 0.001. CONCLUSIONS: Antibiotic prophylaxis with trimethoprim-sulfamethoxazole on urinary catheter removal significantly reduces the rate of symptomatic urinary tract infections and bacteriuria in patients undergoing abdominal surgery with perioperative transurethral urinary catheters.
机译:目的:评估在拔除导尿管时是否进行抗生素预防可降低尿路感染的发生率。背景数据摘要:尿路感染是最常见的医院感染之一。尽管没有支持证据,但在去除导尿管时进行抗生素预防可作为预防措施。方法:一项前瞻性随机研究纳入了239例行选择性腹部手术的患者,这些患者被随机分配接受3剂量的甲氧苄氨嘧啶-磺胺甲基异恶唑在导尿管拔除时是否接受。根据疾病控制中心的定义诊断出尿路感染。在移除导管之前和之后3天获得尿培养物。主观症状由独立的研究盲泌尿科医生评估。结果:接受抗生素预防的患者的尿路感染(5 / 103,4.9%)显着少于未预防抗生素的患者(22 / 102,21.6%),P <0.001。发生尿路感染的绝对风险降低为16.7%;相对风险降低为77.5%,需要治疗的数量为6。抗生素预防患者在拔除导管3天后的显着细菌尿(17/103,16.5%)也比未接受抗生素的患者(42/102,41.2%)少。 ,P <0.001。结论:甲氧苄氨嘧啶磺胺甲基异恶唑对导尿管切除术的预防性抗生素可显着降低围手术期经尿道导尿管进行腹部手术的患者的症状性尿路感染和细菌尿的发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号